WO2014092684A3 - Use of melicope extracts to improve conditions caused by excess lipids - Google Patents

Use of melicope extracts to improve conditions caused by excess lipids Download PDF

Info

Publication number
WO2014092684A3
WO2014092684A3 PCT/US2012/068863 US2012068863W WO2014092684A3 WO 2014092684 A3 WO2014092684 A3 WO 2014092684A3 US 2012068863 W US2012068863 W US 2012068863W WO 2014092684 A3 WO2014092684 A3 WO 2014092684A3
Authority
WO
WIPO (PCT)
Prior art keywords
melicope
extracts
conditions caused
improve conditions
excess lipids
Prior art date
Application number
PCT/US2012/068863
Other languages
French (fr)
Other versions
WO2014092684A2 (en
Inventor
Cheng S. Hwang
Uma Santhanam
Jola Idkowiak Baldys
John W. Lyga
Original Assignee
Avon Products, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avon Products, Inc. filed Critical Avon Products, Inc.
Priority to US13/808,280 priority Critical patent/US9345659B2/en
Priority to PCT/US2012/068863 priority patent/WO2014092684A2/en
Priority to CA2803590A priority patent/CA2803590A1/en
Priority to TW102135892A priority patent/TW201422247A/en
Publication of WO2014092684A2 publication Critical patent/WO2014092684A2/en
Publication of WO2014092684A3 publication Critical patent/WO2014092684A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9755—Gymnosperms [Coniferophyta]
    • A61K8/9767—Pinaceae [Pine family], e.g. pine or cedar
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/31—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9771—Ginkgophyta, e.g. Ginkgoaceae [Ginkgo family]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9794—Liliopsida [monocotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Medical Informatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Methods of using extracts of Melicope to impart anti-lipid benefits to skin and/or improve skin conditions resulting from an over-production of lipids.
PCT/US2012/068863 2012-12-11 2012-12-11 Use of melicope extracts to improve conditions caused by excess lipids WO2014092684A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
US13/808,280 US9345659B2 (en) 2012-12-11 2012-12-11 Use of melicope extracts to improve conditions caused by excess lipids
PCT/US2012/068863 WO2014092684A2 (en) 2012-12-11 2012-12-11 Use of melicope extracts to improve conditions caused by excess lipids
CA2803590A CA2803590A1 (en) 2012-12-11 2013-01-22 Medemia nobilis extracts and methods of use for treating wrinkles
TW102135892A TW201422247A (en) 2012-12-11 2013-10-03 Use of Melicope extracts to improve conditions caused by excess lipids

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2012/068863 WO2014092684A2 (en) 2012-12-11 2012-12-11 Use of melicope extracts to improve conditions caused by excess lipids

Publications (2)

Publication Number Publication Date
WO2014092684A2 WO2014092684A2 (en) 2014-06-19
WO2014092684A3 true WO2014092684A3 (en) 2015-06-11

Family

ID=50935064

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2012/068863 WO2014092684A2 (en) 2012-12-11 2012-12-11 Use of melicope extracts to improve conditions caused by excess lipids

Country Status (3)

Country Link
US (1) US9345659B2 (en)
TW (1) TW201422247A (en)
WO (1) WO2014092684A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10492831B2 (en) 2014-02-21 2019-12-03 Warren R. Hultquist Skin care methods, systems, and devices
US10383816B2 (en) 2015-03-02 2019-08-20 Afgin Pharma, Llc Topical regional neuro-affective therapy with cannabinoid combination products
CN107530318A (en) 2015-03-02 2018-01-02 阿福金制药有限责任公司 Sex therapy is influenceed with the regional area nerve of cannboid
US20180049994A1 (en) 2016-08-16 2018-02-22 Afgin Pharma, Llc Topical regional neuro-affective therapy with caryophyllene
CN110115383A (en) * 2019-06-26 2019-08-13 中国农业大学 A kind of rose Bee Pollen functional food improving acne

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1532938A (en) * 1976-10-14 1978-11-22 Gansloser H Plant extract composition for treating acne
US5200429A (en) * 1990-09-28 1993-04-06 Takasago International Corporation Acne vulgaris treating
US6103241A (en) * 1996-10-23 2000-08-15 Hood; John James David Essential oil and methods of use
US20050186172A1 (en) * 2002-07-08 2005-08-25 Laboratoires Clarins, A Corporation Of France Cosmetic composition capable of fighting against skin aging
US7592024B1 (en) * 2008-12-29 2009-09-22 Avon Products, Inc. Topical compositions containing melicope hayselii and a method of treating skin
US20100048729A1 (en) * 2006-09-15 2010-02-25 Pierre Fabre Dermo-Cosmetique Composition based on xanthoxyline and its use in cosmetic
US20100104671A1 (en) * 2007-02-13 2010-04-29 Legacy Healthcare Holding Ltd. Cosmetic and/or pharmaceutical compositions and their applications
US20100189821A1 (en) * 2007-05-31 2010-07-29 Chan Woong Park Composition of skin external application containing ginseng berry extracts
US20120004302A1 (en) * 2010-06-30 2012-01-05 Avon Products, Inc. Cosmetic Use of N-Substituted Sulfonyloxybenzylamines and Related Compounds
US20120171314A1 (en) * 2010-12-28 2012-07-05 Mary Kay Inc. Sebum control and anti-acne composition

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2740682B1 (en) 1995-11-06 1997-12-05 Oreal TOPICAL COMPOSITION CONTAINING CAPSAZEPINE
US5981575A (en) 1996-11-15 1999-11-09 Johns Hopkins University, The Inhibition of fatty acid synthase as a means to reduce adipocyte mass
JP2004528341A (en) 2001-05-02 2004-09-16 ニューヨーク・ユニバーシティ Inhibition of pigment formation by inhibition of fatty acid synthase
WO2004026249A2 (en) 2002-09-20 2004-04-01 The General Hospital Corporation Methods and compositions for preventing skin damage
US20060134147A1 (en) * 2004-12-21 2006-06-22 Avon Products, Inc. Cosmetic compositions having carnitine creatinate and methods for using
KR20070111635A (en) 2006-05-18 2007-11-22 주식회사 코리아나화장품 Anti-wrinkle cosmetic composition comprising the extract of ilex rotunda as active ingredient
CN100475189C (en) 2006-10-17 2009-04-08 王海龙 Cosmetics composition, preparing method and use thereof
KR100999261B1 (en) 2007-10-09 2010-12-07 (주)아모레퍼시픽 Method for screening inhibitor against hormonal skin aging

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1532938A (en) * 1976-10-14 1978-11-22 Gansloser H Plant extract composition for treating acne
US5200429A (en) * 1990-09-28 1993-04-06 Takasago International Corporation Acne vulgaris treating
US6103241A (en) * 1996-10-23 2000-08-15 Hood; John James David Essential oil and methods of use
US20050186172A1 (en) * 2002-07-08 2005-08-25 Laboratoires Clarins, A Corporation Of France Cosmetic composition capable of fighting against skin aging
US20100048729A1 (en) * 2006-09-15 2010-02-25 Pierre Fabre Dermo-Cosmetique Composition based on xanthoxyline and its use in cosmetic
US20100104671A1 (en) * 2007-02-13 2010-04-29 Legacy Healthcare Holding Ltd. Cosmetic and/or pharmaceutical compositions and their applications
US20100189821A1 (en) * 2007-05-31 2010-07-29 Chan Woong Park Composition of skin external application containing ginseng berry extracts
US7592024B1 (en) * 2008-12-29 2009-09-22 Avon Products, Inc. Topical compositions containing melicope hayselii and a method of treating skin
US20120004302A1 (en) * 2010-06-30 2012-01-05 Avon Products, Inc. Cosmetic Use of N-Substituted Sulfonyloxybenzylamines and Related Compounds
US20120171314A1 (en) * 2010-12-28 2012-07-05 Mary Kay Inc. Sebum control and anti-acne composition

Also Published As

Publication number Publication date
WO2014092684A2 (en) 2014-06-19
TW201422247A (en) 2014-06-16
US20140271953A1 (en) 2014-09-18
US9345659B2 (en) 2016-05-24

Similar Documents

Publication Publication Date Title
IL268075B (en) System to increase the overall diameter of veins and arteries
JO3343B1 (en) Novel5-aminotetrahydroquinoline-2-carboxylic acids and their use
EP3024456A4 (en) Combinatorial methods to improve the therapeutic benefit of bisantrene
EP3068240A4 (en) Theacrine-based supplement and method of use thereof
EP3077046A4 (en) Systems and methods of enhancing electrical activation of nervous tissue
EP2988781A4 (en) Compositions and methods for the therapy and diagnosis of influenza
EP2836270A4 (en) Systems and methods related to the treatment of back pain
EP3010405A4 (en) Method and device to measure biosignal
EP3061326A4 (en) Hybrid generators and methods of using them
MX2016006755A (en) Smooth and bulky towel.
UY34406A (en) COMPOUNDS AND METHODS TO IMPROVE THE INMUNE IMMUNE RESPONSE
EP3039022A4 (en) Compositions and methods for the treatment of metabolic and body weight related disorders
WO2013090228A3 (en) Maesa japonica extracts and methods of use
CA2905610C (en) Hyaluronic acid derivatives
EP3033650A4 (en) Systems and methods of measuring facial characteristics
EP3052078A4 (en) Methods and compositions for improving the appearance of skin
WO2014092684A3 (en) Use of melicope extracts to improve conditions caused by excess lipids
EP3003299B8 (en) Novel n-3 immunoresolvents: structures and actions
EP3672403A4 (en) Methods to improve organ viability
EP3035809A4 (en) Method of maintaining or improving tactical performance through dietary supplementation
ZA201600098B (en) Plant produced human papillomavirus pseudovirion
PL2907321T3 (en) System dedicated to monitoring the physical and/or analogue parameters of the parts of an engine
WO2013120135A9 (en) Systems and methods for providing an assessment score to users
EP3068227A4 (en) Compositions and methods of treatment comprising fosfomycin disodium
EP3052002A4 (en) Detection of nutrient deficiencies influencing ocular health

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 13808280

Country of ref document: US

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12889826

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 12889826

Country of ref document: EP

Kind code of ref document: A2